Background/Aims: Gastric cancer (GC) is a common malignancy with a global incidence that ranks fourth among all tumor types. Epithelial-to-mesenchymal transition (EMT) is a tumor biological process with a role in GC cell metastasis. Long non-coding RNAs (lncRNAs) and microRNAs possess important regulatory functions at the cellular level and in diverse pathophysiological processes. This study was conducted to investigate whether lncRNA RP11-789C1.1 regulates EMT in GC by mediating the miR-5003/E-cadherin pathway. Methods: RP11-789C1.1 and miR-5003 expression was detected in GC specimens and cell lines by quantitative real-time PCR. Western blotting and immunohistochemistry were performed to detect EMT markers in GC. Cell Counting Kit 8 assays were carried out to explore cell proliferation. Wound healing and Transwell assays were conducted to determine the migration and invasion of GC cells. To clarify the correlation between RP11-789C1.1, miR-5003, and E-cadherin, dualluciferase reporter assays were applied. Results: LncRNA RP11-789C1.1 was significantly down-regulated in GC patients and cell lines, along with the concomitant up-regulation of miR-5003. Silencing RP11-789C1.1 and over-expressing miR-5003 significantly promoted the tumor behavior of GC cells. Dual-luciferase reporter assays confirmed that miR-5003 was the target of both RP11-789C1.1 and E-cadherin. Furthermore, at both the mRNA and protein level, silencing RP11-789C1.1 remarkably reduced the expression of E-cadherin and promoted EMT, which were reversed by knocking down miR-5003. Conclusions: LncRNA RP11-789C1.1 inhibited EMT in GC through the RP11-789C1.1/miR-5003/E-cadherin axis, which could be a promising therapeutic target for GC.
Introduction
Gastric cancer is one of the most common malignancies and the second leading cause of cancer-related death worldwide, with a global incidence that ranks fourth among all tumor types [1, 2] . Over the past few decades, despite numerous efforts to improve the survival of patients with gastric cancer, such as improved living standards, a reduction in chronic Helicobacter pylori infections, and remarkable advances in diagnosis and treatment, the 5-year overall survival rate of patients with gastric cancer is still lower than 30%, due to the late advanced stage at which it is diagnosed and the high incidence of tumor metastasis and recurrence [3, 4] . Therefore, there are still considerable clinical challenges regarding how to detect this malignancy early and to improve its prognosis. It is of great importance to identify novel prognostic biomarkers and to elucidate the underlying molecular mechanisms concerning the initiation, development, and metastasis of gastric cancer, and furthermore, to explore additional effective therapeutic approaches for patients with gastric cancer.
Recently, an increasing number of studies has revealed that non-coding RNAs such as microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) play critical roles in the development of cancer [5] [6] [7] . LncRNAs are more than 200 nucleotides in length with no or weak protein coding ability, while microRNAs consist of approximately 22 nucleotides [8, 9] . LncRNAs and miRNAs individually or jointly regulate diverse biological processes, epithelial cell line GES-1 was purchased from the Shanghai Cell Bank of the Chinese Academy of Science (Shanghai, China). AGS, BGC-803, HGC-27, MKN-1, MKN28, and MGC803 cells were cultured in RPMI 1640 (Gibco, Carlsbad, CA, USA), while SGC-7901 and GES-1 cells were cultivated in Dulbecco's modified Eagle's medium (DMEM; Gibco) supplemented with 10% fetal bovine serum (Gibco) and 0.1% penicillin/ streptomycin (Invitrogen, Carlsbad, CA, USA). The cells were incubated and maintained in a humidified atmosphere of 5% CO 2 at 37°C.
RNA extraction and quantitative real-time reverse transcription PCR analysis
Total RNA was isolated from clinical specimens and cell lines using the TRIzol reagent (Invitrogen, Carlsbad, CA, USA). Real-time quantitative reverse transcription PCR (qRT-PCR) was performed with a standard SYBR Green PCR Kit (TaKaRa, Dalian, China) on a LightCycler 480 platform (Roche, Meylan, France). The expression of mRNAs and lncRNAs was normalized to the levels of glyceraldehyde-3-phosphate dehydrogenase (GAPDH), while miRNAs were normalized to U6. The specific primers for mRNAs are presented in Table 1 . The data were collected and analyzed using the 2 -ΔΔCt method.
Cell transfection
A riboFECT CP Transfection Kit (RiboBio, Guangzhou, China) was used for transfection according to the product description. RP11-789C1.1 small interfering RNA (siRNA-RP) and scrambled siRNA (siRNA-NC), as well as pcDNA3.1-RP11-789C1.1 (pcDNA-RP) and pcDNA3.1-control (pcDNA-NC) were obtained from iGeneBio (Guangzhou, China). miRNA-5003-3p mimic (miR-5003), miR-5003-3p mimic control (miR-NC), miR-5003-3p inhibitor (in-miR-5003), and inhibitor control (in-miR-NC) were purchased from RiboBio (Guangzhou, China).
Cell proliferation assay
Cell viability was measured using a Cell Counting Kit 8 (CCK8) (Dojindo, Kumamoto, Japan). The cells were transfected with miRNA, siRNA, or pcDNA3.1 and grown on 96-well plates. Cell viability was monitored every 24 h according to the manufacturer's protocol.
Wound-healing assay Cells (3.0 × 10 5 ) transfected with miRNA, siRNA, or pcDNA3.1 were plated on 6-well plates and cultured for monolayer formation. The cell layer was scratched with a sterile plastic tip. After washing with phosphate-buffered saline 3 times, the cells were cultured in DMEM (Gibco) or RPMI 1640 supplemented with 1% fetal bovine serum (Gibco). Images of the plates were captured under a microscope at 0 and 48 h after scratching. Digimizer image analysis software was used to measure the distance between the two edges of the scratch.
Cell migration and invasion assays
Transwell inserts with 8-μm pore size polycarbonate (Corning, Inc., Corning, NY, USA) were applied for cell migration and invasion assays. For the migration assays, 5.0 × 10 4 cells in serum-free medium were placed in the upper chamber. For the invasion assays, 5.0 × 10 4 cells in serum-free medium were placed in the upper chamber, which was coated with Matrigel (BD Biosciences, Franklin Lakes, NJ, USA). DMEM or RPMI 1640 with 10% fetal bovine serum was added to the lower chamber. The cells were incubated for 48 h. The cells on the lower membrane surface were considered to be migrated or invaded cells. These cells were fixed with methanol for 20 min and stained with 0.1% crystal violet. Images were captured under a microscope and the number of migrated or invaded cells was counted.
Western blot analysis
The cells were harvested and total protein was extracted using RIPA protein extraction reagent (Beyotime, Beijing, China) supplemented with phenylmethylsulfonyl fluoride (Roche, Pleasanton, 
Immunohistochemical staining
Paraformaldehyde-fixed paraffin-embedded sections were dewaxed and dehydrated. After rehydration and antigen retrieval with a citrate buffer, endogenous peroxidase activity was blocked by H 2 O 2 (3.0%). The sections were blocked with 10% goat plasma for 30 min. Primary antibodies against E-cadherin (1:400; Abcam) were added to the sections and incubated at 4°C overnight. Detection of the primary antibodies was performed using biotinylated secondary antibodies. Hematoxylin was used for counterstaining.
RNA pull-down assay
For pull-down assays of biotinylated miR-5003, miR-5003-mut and control were synthesized and transfected into MKN-1 and SGC-7901 cells. The cells were then collected and lysed. According to the product description, a portion of extract was used for input and another portion was incubated with Dynabeads M-280 Streptavidin (Invitrogen). RNA was purified with an RNA Isolation Kit (QIAGEN, Valencia, CA, USA) and used for qRT-PCR assays.
For pull-down assays of the biotinylated DNA probe, the complementary and biotinylated probe of RP11-789C1.1 was obtained and Dynabeads M-280 Streptavidin (Invitrogen) was used to generate probecoated beads. The probe-coated beads were incubated with lysates from MKN-1 and SGC-7901 cells. The binding RNAs were then collected and used for qRT-PCR.
Dual luciferase reporter assay
The binding sites between miR-5003-3p and RP11-789C1.1 or E-cadherin were predicted by bioinformatics tools (microRNA.org, Starbase v2.0, and miRcode). Dual luciferase reporters were constructed according to the procedures described in our previous study [21] . A Dual Luciferase Reporter Assay System (Promega, Madison, WI, USA) was applied to measure luciferase activity. Renilla luciferase activity was used for normalization. The experiments were repeated independently 3 times.
Statistical analysis
Data are presented as the mean ± standard error of the mean. All statistical analyses were performed using SPSS 19.0 statistical software (SPSS, Inc., Chicago, IL, USA). Student's t-test (2-tailed), one-way analysis of variance, and the Mann-Whitney U test were used for statistical analyses. P-values less than 0.05 were considered statistically significant.
Results

LncRNA RP11-789C1.1 suppresses the proliferation of gastric cancer cells
We previously demonstrated that lncRNA RP11-789C1.1 was significantly downregulated in gastric cancer specimens and was closely associated with patient prognosis. Therefore, we sought to further evaluate the biological role of RP11-789C1.1 in gastric cancer cells. Compared with the normal gastric epithelial cell line GES-1, RP11-789C1.1 was found to be remarkably down-regulated in all 7 gastric cancer cell lines examined (Fig. 1A) . We then randomly selected 2 gastric cancer cell lines for over-expression or knockdown assays. pcDNA-RP was transfected into MKN-1 cells for the over-expression of RP11-789C1.1, and siRNA-RP was transfected into SGC-7901 cells for the knockdown of RP11-789C1.1. pcDNA-NC or siRNA-NC was also transfected into these cells as a respective control group. Transfection efficiency was validated by qRT-PCR (Fig. 1B) . CCK8 assays were conducted to explore the impact of RP11-789C1.1 on gastric cancer cells. The results indicated that RP11-789C1.1 over-expression significantly reduced the proliferation of MKN-1 cells, while RP11-789C1.1 knockdown remarkably enhanced the proliferation of SGC-7901 cells (Fig. 1C) . These results demonstrated that lncRNA RP11-789C1.1 could suppress the proliferation of gastric cancer cells.
LncRNA RP11-789C1.1 suppresses the migration, invasion, and EMT of gastric cancer cells
To further determine whether RP11-789C1.1 could have an impact on the progression of gastric cancer, we explored its effect on the migration and invasion of MKN-1 and SGC-7901 cells. Using a wound healing assay, we found that MKN-1 cells transfected with pcDNA-RP had a slower scratch closure rate than the control group. SGC-7901 cells transfected with siRNA-RP had a faster scratch closure rate than the control group (Fig. 1D) . Using Transwell migration assays (without Matrigel) and Transwell invasion assays (with Matrigel), we found that the mobility and invasiveness of MKN-1 cells were dramatically suppressed following RP11-789C1.1 over-expression. In parallel, the reduced expression of RP11-789C1.1 remarkably promoted the migration and invasion of SGC-7901 cells when compared with the control group (Fig. 1E) . Moreover, the results of functional experiments with GES-1 cells were consistent with the results in gastric cancer cells (for all online suppl. material, see www.karger.com/doi/10.1159/000491617, Fig. S1A ). Thus, we concluded that lncRNA RP11-789C1.1 could significantly inhibit the migration and invasion of gastric cancer cells. EMT is associated with the progression and metastasis of gastric cancer cells; therefore, we explored whether RP11-789C1.1 had any influence on the EMT of gastric cancer cells. Immunohistochemistry was firstly performed to explore the association between RP11- and see online suppl. material, S1B). These results indicated the potential regulation of EMT by RP11-789C1.1 in gastric cancer. In addition, EMT markers (E-cadherin, N-cadherin, vimentin, MMP-2, and MMP-9) were analyzed in gastric cancer cells following the overexpression or knockdown of RP11-789C1.1. qRT-PCR analysis revealed that RP11-789C1.1 over-expression significantly enhanced the expression of E-cadherin, while it reduced the expression of N-cadherin, vimentin, MMP-2, and MMP-9. Conversely, knockdown of RP11-789C1.1 decreased E-cadherin expression, while it increased the expression of N-cadherin, vimentin, MMP-2, and MMP-9 (Fig. 2B, C) . Consistently, western blot analysis demonstrated that enhanced RP11-789C1.1 expression could remarkably elevate the expression of E-cadherin and reduce the expression of N-cadherin, vimentin, and Snail, while silencing RP11-789C1.1 generated the opposite expression pattern (Fig. 2D) . Thus, these results indicated that RP11-789C1.1 reversely mediated EMT in gastric cancer cells.
LncRNA RP11-789C1.1 directly targets miR-5003-3p in gastric cancer
To uncover the underlying molecular mechanism by which RP11-789C1.1 influences the progression of gastric cancer, the online bioinformatics tool FINDTAR3 (https://bio. sz.tsinghua.edu.cn) was applied to identify potential targets of RP11-789C1.1. Bioinformatics analysis indicated that miR-5003-3p was a potential target of RP11-789C1.1, which contains a putative 9 base-pair binding site (Fig. 3A) . We then used qRT-PCR to assess the expression of miR-5003-3p in 30 paired gastric cancer tissues, consisting of gastric cancer and adjacent normal tissues. miR-5003-3p was found to be dramatically up-regulated in gastric cancer tissues when compared with adjacent normal tissues (Fig. 3B) . We also explored the expression pattern of miR-5003-3p and RP11-789C1.1 in these gastric cancer specimens by qRT-PCR. The data showed there was a negative association between miR-5003-3p and RP11-789C1.1 in gastric cancer specimens (Fig. 3C ). In addition, we examined miR-5003-3p expression in the GES-1, MKN-1, and SGC-7901 cell lines. miR-5003-3p was found to be upregulated in MKN-1 and SGC-7901 cells when compared with GES-1 cells. Next, miR-5003-3p inhibitors or mimics were transfected into MKN-1 and SGC-7901 cells. Transfection efficiency was validated by qRT-PCR (Fig. 3D) . Then, luciferase reporter assays were conducted to verify whether RP11-789C1.1 binds to miR-5003-3p directly. The wild-type 3′ untranslated region (UTR) of RP11-789C1.1 (wt-RP) and mutant 3′ UTR of RP11-789C1.1 (mut-RP) were cloned into reporter plasmids, respectively. miR-5003-3p was found to reduce the luciferase activity of wt-RP significantly; however, this reduction was not observed using mut-RP (Fig.  3E) . Biotin-labeled pull-down assays also indicated that RP11-789C1.1 could target miR-5003-3p directly (see online suppl. material, Fig. S3 ). Furthermore, miR-5003-3p expression was examined in MKN-1 cells, which were transfected with pcDNA-RP, and SGC-7901 cells, which were transfected with siRNA-RP. miR-5003-3p expression was found to be negatively regulated by RP11-789C1.1 in MKN-1 and SGC-7901 cells (Fig. 3F) . Moreover, qRT-PCR also revealed that RP11-789C1.1 expression could be enhanced or reduced by modulating the expression of miR-5003-3p in MKN-1 and SGC-7901 cells (Fig. 3G) . Thus, we concluded that RP11-789C1.1 targeted miR-5003-3p directly in gastric cancer cells.
miR-5003-3p promotes migration, invasion, and EMT by directly targeting E-cadherin in gastric cancer
miR-5003-3p has been shown to be associated with breast cancer metastasis [22] , but its role in gastric cancer is still largely elusive. MKN-1 and SGC-7901 cells were transfected with miR-5003-3p inhibitors or mimics and wound healing and Transwell assays were conducted. The wound healing assays demonstrated that MKN-1 cells transfected with miR-5003-3p inhibitors had a slower scratch closure rate than the control group (Fig. 4A) . Conversely, SGC-7901 cells transfected with miR-5003-3p mimics exhibited a faster scratch closure rate than the control group (Fig. 4B) . The Transwell migration assays (without Matrigel) suggested (Fig. 4C, D) . The Transwell invasion assays (with Matrigel) showed consistent results (Fig. 4C, D) . We then explored whether miR-5003-3p had an influence on the EMT of gastric cancer cells by using immunohistochemistry, qRT-PCR, and western blot analyses. The association between miR-5003-3p and the EMT marker E-cadherin was validated by immunohistochemistry. E-cadherin expression was found to be remarkably increased in low miR-5003-3p tissues compared with high miR-5003-3p tissues (Fig. 4E) . N-cadherin and Vimentin expression were found to be remarkably increased in high miR-5003-3p tissues compared with low miR-5003-3p tissues (see online suppl. material, Fig. S2 ). qRT-PCR demonstrated that miR-5003-3p over-expression enhanced the expression of N-cadherin, vimentin, MMP-2, and MMP-9, while it decreased the expression of E-cadherin. Conversely, miR-5003-3p knockdown enhanced the expression of E-cadherin and reduced the expression of N-cadherin, vimentin, MMP-2, and MMP-9 (Fig. 5A, B) . Western blot analysis generated similar results (Fig. 5C, D) . In order to explore the molecular biological mechanisms by which miR-5003-3p promotes migration, invasion, and EMT in gastric cancer, bioinformatics prediction programs (TargetScan, miRanda, and DIANA) were used to identify putative target genes. E-cadherin was predicted as putative target of miR-5003-3p and potential binding sequences were identified (Fig. 5E ). E-cadherin has been shown to be a downstream target of miR-5003-3p in breast cancer [22] , but whether it is regulated by miR-5003-3p in gastric cancer is unknown. As presented in Fig. 5E , we generated 2 luciferase reporters that contained the 3 putative binding sites. Luciferase reporter assays revealed that miR-5003-3p over-expression could reduce the activity of E-cadherin-2, but not E-cadherin-1 (Fig. 5F ), suggesting that the miR-5003-3p-targeted sequences were contained in the E-cadherin-2 reporter. We then constructed 3 mutant reporters as presented in Fig. 5E , and these reporters were individually co-transfected with the miR-5003-3p mimic. Luciferase activity was found to be repressed in a single mutant reporter, but not in the double mutant Wound healing assays were performed to investigate cell migration after miR-5003-3p up-regulation. C. Transwell assays were performed to identify changes in the migratory and invasive abilities of gastric cancer cells after transfection with in-miR-5003 or controls. D. Transwell assays were performed to identify changes in the migratory and invasive abilities of gastric cancer cells after transfection with miR-5003 or controls. E. E-cadherin immunostaining was weakly positive in gastric cancer tissues with relatively high miR-5003-3p expression, while E-cadherin immunostaining was strongly positive in gastric cancer tissues with low miR-5003-3p expression. *P<0.05; **P<0.01. 
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reporter, which confirmed that miR-5003-3p directly targeted the 3′ UTR of E-cadherin at sites A and B (Fig. 5) . Another group of luciferase reporter assays indicated similar results (Fig. 5G) . Taken together, we came to the conclusion that miR-5003-3p promoted migration, invasion, and EMT in gastric cancer by directly targeting E-cadherin.
Suppressive effects of RP11-789C1.1 on migration, invasion, and EMT in gastric cancer are mediated by miR-5003-3p/E-cadherin
To explore whether the effects of RP11-789C1.1 on migration, invasion, and EMT in gastric cancer were mediated by miR-5003-3p/E-cadherin, MKN-1 cells were co-transfected with pcDNA-RP and miR-5003, whereas siRNA-RP and in-miR-5003 were transfected into SGC-7901 cells. The detection of E-cadherin mRNA expression demonstrated that pcDNA-RP increased E-cadherin expression remarkably, which was repressed by miR-5003 (Fig. 6A) . Conversely, there was a decrease of E-cadherin expression in siRNA-RP-transfected cells, which could be rescued by in-miR-5003 (Fig. 6B) . Meanwhile, co-transfection of pcDNA-RP and miR-5003 clearly reversed the expression of miR-5003-3p compared with pcDNA-RP transfection alone (Fig. 6C) . The detection of miR-5003-3p expression in SGC-7901 cells illustrated similar results (Fig. 6D) . Transwell assays demonstrated that the anti-metastatic effects of RP11-789C1.1 over-expression on MKN-1 cell migration and invasion could be attenuated by miR-5003 (Fig. 6E) . Conversely, miR-5003-3p knockdown repressed the migration and invasion of RP11-789C1.1-silenced SGC-7901 cells (Fig. 6F) . In addition, the stimulative effects of RP11-789C1.1 silencing on the promotion of EMT could be reversed by miR-5003-3p knockdown (Fig. 6H) . Consistently, western blot analysis demonstrated that miR-5003-3p over-expression could dramatically reverse the suppressive effects of RP11-789C1.1 on the progression of EMT in gastric cancer cells (Fig. 6G) . Taken together, these results suggested that miR-5003-3p/E-cadherin mediated the suppressive effects of RP11-789C1.1 on migration, invasion, and EMT in gastric cancer.
Discussion
Being important members of the non-coding RNA family, lncRNAs have been found to be associated with many physiological and pathological processes, such as cell growth, differentiation, development, and tumorigenesis [23] [24] [25] . For their role in tumorigenesis, the aberrant expression of lncRNAs has an impact not only on cancer cell proliferation and metastasis and as prognostic factors [26] but also on EMT, tumor drug resistance, and cancer stem cells [27, 28] . RP11-789C1.1 was identified initially in our previous study as a specific lncRNA that was significantly downregulated in gastric cancer tissues when compared with adjacent normal tissues [19] . It was also shown that RP11-789C1.1 expression was lower In this study, we explored and analyzed the biological function of RP11-789C1.1 in gastric cancer cells. Consistent with our previous speculation, the results of the present study suggested that RP11-789C1.1 could significantly suppress gastric cancer cell growth, migration, and invasion. Some studies have shown that lncRNAs can inhibit the progression of gastric cancer. Zhao et al. found that lncRNA SNHG5 was significantly downregulated in gastric cancer and it suppressed gastric cancer cell proliferation and metastasis in vitro and in vivo by trapping MTA2 [29] . LncRNA AF147447 could repress gastric cancer cell proliferation and invasion via MUC2 and miR-34c [30] . To the best of our knowledge, this is the first study to illustrate the biological function of RP11-789C1.1 in cancer cells.
RP11-789C1.1 was differentially identified from metastatic gastric cancer tissues and non-metastatic tissues, so we focused on its role in metastasis. EMT is a vital process in the progression of cancer cell metastasis, and accepted biomarkers of EMT include the reduced expression of E-cadherin and enhanced expression of N-cadherin and vimentin [31] . It has been revealed that lncRNAs, miRNAs, and EMT are closely related or associated with each other in a variety of tumor types [32] . We thus explored the expression of EMT markers in gastric cancer cells in which RP11-789C1.1 was over-expressed or knocked down, and found that RP11-789C1.1 could inhibit the progression of EMT. These results, interestingly, correlated with our previous study in which the upregulation of lncRNA XLOC-010235 in gastric cancer cells promoted EMT [20] . Both of these lncRNAs were identified with the same microarray and were validated using clinical specimens. Future studies should explore whether there is any connection or regulatory network between these lncRNAs in gastric cancer cells, which may help to strengthen our understanding of their biological roles in tumor progression.
LncRNAs can act as ceRNA sponges for miRNAs to regulate downstream genes and exert vital roles in physiological and pathological processes [33] . Herein, we firstly identified that RP11-789C1.1 could target miR-5003-3p directly to suppress the migration, invasion, and EMT of gastric cancer cells. miR-5003-3p was previously screened as an EMT-regulating miRNA that could induce the upregulation of Snail and enhance the formation of metastatic nodules in the lungs of mice. The present study revealed that miR-5003-3p promoted migration, invasion, and EMT in gastric cancer. Moreover, E-cadherin was also identified as a direct target of miR-5003-3p in gastric cancer. To the best of our knowledge, this study is also the first to verify the tumor-promoting role of miR-5003-3p in gastric cancer cells. Subsequently, whether RP11-789C1.1 could regulate the expression of E-cadherin and EMT by targeting miR-5003-3p was validated and the mutual adjustments between RP11-789C1.1 and miR-5003-3p were verified.
In conclusion, our study suggested that lncRNA RP11-789C1.1 could inhibit gastric cancer cell migration, invasion, and EMT. Moreover, the antitumor function of RP11-789C1.1 was mediated by the RP11-789C1.1/miR-5003-3p/E-cadherin axis. Our study provides a new hypothesis for the study and treatment of gastric cancer and suggests that the RP11-789C1.1/miR-5003-3p/E-cadherin axis may serve as a prospective therapeutic target for gastric cancer.
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